Elias2025 - Physiologically based pharmacokinetics (PBPK) model glimepiride
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Initial model release
应用场景：
创建时间：
2025-10-15
相关数据集
A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
Interventions: On Day 1, patients treated with FOLFIRI therapy received a 2-hour intravenous infusion of CPT-11 (150 mg/m2) combined with 1-LV (200 mg/m2), followed by a rapid intravenous infusion of
NIAID Data Ecosystem60
Demography in Pharmacokinetics of Sildenafil in Premature Infants
Demographic data Study Description This was a phase I, open-label, pharmacokinetic (PK) study with a primary objective of determining PK of sildenafil in premature infants. The trial enrolled 25 prema
NIAID Data Ecosystem30
Vancomycin pharmacokinetic model development in patients on intermittent online hemodiafiltration
BackgroundVancomycin is frequently used in hemodialysis (HD) and in hemodiafiltration (HDF) patients and is usually administered in the last 30 or 60 minutes of a dialysis session. Vancomycin pharmaco
Figshare2019-05-14 更新00
Non-genetic factors influencing the warfarin maintenance dose.
*The correlation was analyzed with linear regression.
NIAID Data Ecosystem40
Parameter estimates of the final population PK model of benznidazole.
Parameter estimates of the final population PK model of benznidazole.
NIAID Data Ecosystem10
